BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 23100219)

  • 1. CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches.
    Whitman IR; Feldman HI; Deo R
    J Am Soc Nephrol; 2012 Dec; 23(12):1929-39. PubMed ID: 23100219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay between CKD, sudden cardiac death, and ventricular arrhythmias.
    Pun PH
    Adv Chronic Kidney Dis; 2014 Nov; 21(6):480-8. PubMed ID: 25443573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.
    Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS
    JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
    Makki N; Swaminathan PD; Hanmer J; Olshansky B
    Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator.
    Hoffmeister JM; Estes NA; Garlitski AC
    J Interv Card Electrophysiol; 2012 Nov; 35(2):227-34. PubMed ID: 22956011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD.
    Khattak A; Charytan DM
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1107-9. PubMed ID: 26111858
    [No Abstract]   [Full Text] [Related]  

  • 7. Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Sudden Cardiac Death.
    Shafi T; Guallar E
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1429-1431. PubMed ID: 30111586
    [No Abstract]   [Full Text] [Related]  

  • 8. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Bansal N; Szpiro A; Masoudi F; Greenlee RT; Smith DH; Magid DJ; Gurwitz JH; Reynolds K; Tabada GH; Sung SH; Dighe A; Cassidy-Bushrow A; Garcia-Montilla R; Hammill S; Hayes J; Kadish A; Sharma P; Varosy P; Vidaillet H; Go AS
    Heart; 2017 Apr; 103(7):529-537. PubMed ID: 27742796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable Cardioverter Defibrillators and Chronic Kidney Disease.
    Kiage JN; Latif Z; Craig MA; Mansour N; Khouzam RN
    Curr Probl Cardiol; 2021 Mar; 46(3):100639. PubMed ID: 32624194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden cardiac death and chronic kidney disease: From pathophysiology to treatment strategies.
    Di Lullo L; Rivera R; Barbera V; Bellasi A; Cozzolino M; Russo D; De Pascalis A; Banerjee D; Floccari F; Ronco C
    Int J Cardiol; 2016 Aug; 217():16-27. PubMed ID: 27174593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management and prevention of sudden cardiac death.
    Yousuf O; Chrispin J; Tomaselli GF; Berger RD
    Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death in chronic kidney disease: epidemiology and prevention.
    Shamseddin MK; Parfrey PS
    Nat Rev Nephrol; 2011 Mar; 7(3):145-54. PubMed ID: 21283136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillators in chronic kidney disease.
    Mc Causland FR; Pfeffer MA
    Nat Rev Nephrol; 2018 Jun; 14(6):357-358. PubMed ID: 29651098
    [No Abstract]   [Full Text] [Related]  

  • 15. Sudden cardiac death in postmyocardial-infarction patients.
    Fahed J; Floyd KC; Tighe DA
    Panminerva Med; 2015 Jun; 57(2):71-86. PubMed ID: 25669163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Renal Dysfunction on Risk of Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Higuchi S; Minami Y; Shoda M; Shirotani S; Kanai M; Kataoka S; Yazaki K; Saito C; Haruki S; Yagishita D; Ejima K; Hagiwara N
    Am J Cardiol; 2021 Apr; 144():131-136. PubMed ID: 33383012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of death in chronic kidney disease: the role of implantable cardioverter defibrillators.
    Turner S; Onalan O; Bickle B
    CANNT J; 2009; 19(3):29-36; quiz 37-8. PubMed ID: 19899497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do implantable defibrillators help patients with CKD?
    Charytan DM; Reynolds MR
    Am J Kidney Dis; 2014 Jul; 64(1):4-6. PubMed ID: 24954452
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D
    J Am Coll Cardiol; 2018 Oct; 72(14):1653-1676. PubMed ID: 29097297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
    Fallavollita JA; Dare JD; Carter RL; Baldwa S; Canty JM
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.